About us
The UCL Cancer Institute is a £40 million investment in central London based at University College London (UCL), one of the world's top universities and a founding member of the Crick Institute.
Mission and Strategy
This is an exciting time for cancer research and treatment. Discover the goals of the UCL Cancer Institute.
Clinical and interdisciplinary networks
UCL Cancer Institute draws together over 400 scientists working together to develop world-class basic and translational cancer research. Through our associations with UCL Hospitals NHS Foundation Trust, Great Ormond Street Hospital and the Royal Free Hospital NHS Foundation Trust, the Institute has greater clinical links than any comparable centre in the UK and a significant impact on the delivery of clinical service to cancer patients.
This concentration of excellence, access to patients and significant recent investment of cancer treatment and research infrastructure, makes UCL a global leader. The Institute exemplifies UCL's distinctive cross-disciplinary approach, bringing together varied disciplinary expertise and theoretical perspectives to advance our understanding of the complexities of cancer and the development of improved diagnostics and treatments.
Partners and Collaborations
We exploit UCL's interdisciplinary nature by engaging a wide range of disciplines – from engineering, to physics, to population health sciences and nanoscience – to transform cancer research.
Looking after our people
Athena SWAN
UCL Cancer Institute is proud to hold a Gold Athena SWAN award in recognition of the the good practice and progress we have made in advancing the careers of women in science.
Careers and Staff Development
Explore current opportunities within the Cancer Institute, and how we support career development.
CI Postdoc Society
We are a group of approximately 100 members. Postdoctoral researchers can develop their personal and academic skills through a variety of career development workshops, courses and scientific events.
Safety at the Cancer Institute
Potentially, anyone is at risk while at work. We ensure that health, safety and welfare are at the forefront of the Cancer Institute, while supporting the ongoing research taking place at our sites.
UCL Cancer Institute awarded Athena SWAN Gold
The UCL Cancer Institute has been awarded Athena SWAN Gold status - a prestigious national recognition of its sustained commitment to advancing gender equality in higher education and research.
Research departments
UCL Cancer Institute is structured around four research departments that span our three Institute sites at UCL and the Royal Free Hospital.
Department of Cancer Biology and Pathology
We research vital strands around cancer biology and pathology, including cell science, medical and regulatory genomics, and sarcoma biology.
Department of Haematology
We research vital strands in Haematology, including immune regulation and immunotherapy, multiple myeloma and UCL's CAR-T programme.
Department of Oncology
We research vital strands in Oncology, including brain cancer biology, cancer metastasis, glioblastoma and treatment resistance.
Department of Clinical Trials
The Cancer Research UK and UCL Cancer Trials Centre forms the Clinical Trials research department within UCL Cancer Institute and is part of the Cancer Research UK-UCL Centre.
Contact
UCL Cancer Institute
Paul O'Gorman Building
72 Huntley Street
London, WC1E 6DD
